At the Big Data in Precision Health conference, clinicians discussed using patient health data to enhance primary care through the Humanwide pilot project.
Speakers at Stanford's Big Data in Precision Health conference discuss how their work with big data impacts and informs sleep research.
Stanford Medicine's Big Data in Precision Health conference unites people who create, study and use information from big data to improve health.
Stanford researchers, seeking ways to regenerate muscle after injury, find a promising method using collagen and vascular cells.
Eddie Shakerpour wanted to feel better, so he joined Humanwide, a Stanford Medicine pilot that used data to create personalized, preventive care plans.
The Digital Health in the Rural American West workshop addressed health disparities that are often overlooked and understudied in the vast region.
Before the Big Data in Precision Health conference, Don Rucker, the national coordinator for health IT, discusses the government's role in health data.
A team of Stanford researchers has developed a new model to more accurately identify proteins from a mass spectometry sample.
Stanford Medicine's Humanwide pilot project offers a promising model for personalized, patient-centered, data-driven primary care.
New Stanford research suggests a method of analyzing cell-phone videos of children could alleviate the bottleneck in autism diagnosis around the world.
Stanford scientists and their collaborators tracked the health of over 100 people for several years, flagging early signs of disease.
While promoting diversity within its programs, Stanford Biodesign is also working to foster gender diversity in the medtech industry.
Construction crews are putting the finishing touches on the new Stanford Hospital, getting ready for it to open later this year.
Millions of people are at risk from inadequate or unreliable lighting during surgery, so a Stanford surgeon is part of a team developing an affordable surgical headlamp.
At a recent Dean's Lecture Series, Dean Lloyd Minor discussed organizational culture and diversity with Emma Walmsley, CEO of GlaxoSmithKline.
A radio show features a Stanford oncologist discussing ultra-fast "flash" radiation therapy, which may kill cancer cells with less collateral damage.
